TD Cowen raised the firm’s price target on Gilead (GILD) to $100 from $95 and keeps a Buy rating on the shares. The firm said they posted a ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Gilead said its fourth-quarter HIV product sales rose to $5.45 billion from $4.69 billion a year earlier, due to higher ...

Salesforce has announced a new CFO+ with an expanded set of responsibilities as a company veteran who "bleeds CRM" prepares ...

California Democratic Rep. Jared Hoffman protested the National Prayer Breakfast Thursday, claiming it violates the separation between church and state. The congressman said in an X video […] ...

A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the ...

Gilead KOA Holiday has been recognized with the prestigious KOA ICON Award. This recognition highlights campgrounds that demonstrate exceptional operational excellence, customer satisfaction, and a ...

Sexyy Red joined the many social media users who paid tribute to Rev. Dr. Martin Luther King by sharing an AI-generated image of herself and the late, great civil rights icon on X. The “U My ...

Five years ago, Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at the original signing. Gilead had reached an inflection point ...

Ivanka Trump wore a timeless remake of a Givenchy dress at tonight's inauguration ball after sporting a green ensemble ahead of the inauguration which reminded some of a dystopian story ...

Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...